**These sessions will be held virtually on Zoom. The link will be sent to those who register with a BWH/MGH/MGB-affiliated email address 1-2 days prior to the session**

It is the expectation of Mass General Brigham and its affiliated hospitals that all members of the Mass General Brigham research community will perform their research in accordance with the highest ethical and professional standards. Principal Investigators, as leaders of scientific projects, are responsible for the scientific integrity of work undertaken in their laboratories and for mentoring the investigators, postdoctoral fellows, and students who work on these projects. Educating staff, fellows, and students in research best practices is the foundation for discouraging scientific misconduct and promoting research integrity. Read more about Responsible Conduct of Research (RCR) Training.

Who is required to complete ​RCR training?

​RCR training is required of all trainees, postdoctoral fellows, students and career-development recipients supported by training grants (e.g., T32, F32, all K-awards) identified in the NIH notice dated November 24, 2009; and NSF training and research grant supported students and postdoctoral fellows as identified in the Federal Register notice dated August 20, 2009.​

​What are the MGB RCR Program requirements?

​The MGB RCR Program consists of three parts:

1) MGB Seminar – Offered three times a year alternating between the BWH and MGH campuses;

2) On-line training through the CITI (Collaborative Institutional Training Initiative) RCR Modules; and

3) Participation in no less than four hospital-based lecture/discussion offerings identified as eligible for RCR credit.

Read other FAQs

The sessions below fulfill Part 3 of the RCR requirement outlined above.

  • Mon, Jan 31, 2022 | 2:00PM - 3:00PM | The Peer Review Process for Manuscripts | Gary Curhan, MD, ScD | virtual (Zoom)

  • Mon, Feb 7, 2022 | 3:00PM - 4:00PM | IRB 101: Collaboration, Partnership, and Research Ethics | Benjamin Silverman, MD | virtual (Zoom)

  • Tues, March 29, 2022 | 1:00PM - 2:00PM | Academic Medicine, Industry, and Collaborative Research in the Era of Emerging Technologies and Precision Health | Samia Mora, MD, MHS | virtual (Zoom)

  • Thurs, April 7, 2022 | 1:00PM - 2:00PM | Managing and Reporting Unanticipated Problems Including Adverse Events | Prapti Bisht, MBA, CIP | virtual (Zoom)

  • Tues, April 26, 2022 | 2:00PM - 3:00PM | Review Integrity & Confidentiality | Hadi Shafiee, PhD | virtual (Zoom)

  • Tuesday, May 10, 2022 | 1:00PM - 2:00PM | FDA Inspections, 483s, and Warning Letters | Pamela Richtmyer | virtual (Zoom)

  • Thursday, Sep 29, 2022 | 1:00PM - 2:00PM | Issues Related to Withdrawing Participants from Study Protocols: Case Studies | Gail Adler, MD, PhD | virtual (Zoom)

  • Wednesday, Oct 19, 2022 | 10:00AM - 11:00AM | Misconduct of Research Integrity | Paul Anderson, MD, PhD | virtual (Zoom)

  • Monday, Nov 7, 2022 | 1:00PM - 2:00PM | Tissue Issues: IRB Perspectives | Martha Jones, MA, CIP | virtual (Zoom)

  • Thursday, Dec 8, 2022 | 2:00PM - 3:00PM | Societal Impacts of Clinical Research | Gad Marshall, MD | virtual (Zoom)
Loading... Loading...
You have selected an option that triggers this survey to end right now.
To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.